About Us

Prostate cancer

Urothelial cancer

Epidemiology

Functional Urology

Andrology

Pediatric urology

People

Research Objectives

We investigate clinical, epidemiological, pathological, molecular and genetic characteristics of urological diseases. Our goal is to improve urological healthcare, from the general practitioner to tertiary academic care.

Collaborations

The Department of Urology of the Erasmus University Medical Center, Rotterdam, is embedded in the dynamic, internationally competitive research community of  several clinical, translational and basic research groups. Our focus lies in Protate Cancer, Urothelial Cancer, Functional Urology, Andrology and Pediatric Urology. We have longstandig collaborations with multiple other acadamic centers, both internationally and at a national level, and host fruitful relationships with our industry partners. Our department is renowed for participation at the highest level to improve European Patient Guidelines.

Academic Excellence

Our motto: “research” = care. We aim to improve the diagnosis, treatment and outcome in patients with urologic diseases by translational, clinical and epidemiological research, and education of students and professionals. Providing excellent academic care at a tertiary level is in our DNA. Do you want to be part of our team, either as as aspiring researcher or student, don’t hesitate to send your contact information to one of our Principal Investigators.

The Department of Urology is placed in the Staff Tower (Na buidling), the Erasmus MC Cancer Institute (Be building) and in the research tower (Ee building). The Department Chair is Dr. Joost L. Boormans.

Latest news

New publication: Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

Abstract Background: Active surveillance (AS) is a management option for men diagnosed with low-risk prostate cancer. Opinions differ on whether...
Read More

New publication: A Urine-based Genomic Assay Improves Risk Stratification for Patients with High-risk Hematuria Stratified According to the American Urological Association Guidelines

Abstract Background: According to the recent American Urological Association (AUA) guideline on hematuria, patients are stratified into groups with low, intermediate,...
Read More

New publication: Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

Abstract In the pre-PSA-detection era, a large proportion of men were diagnosed with metastatic prostate cancer and died of the...
Read More

Darts against Cancer

In this year’s edition, the Bullseye Foundation raised more than 10,000 euros with Darts against Cancer. For over 10 years, the...
Read More

New publication: Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case-control matching study

Abstract Objectives: To assess survival of patients with muscle-invasive bladder cancer (MIBC) who underwent radical cystectomy (RC) with or without neo-adjuvant...
Read More

New publication: A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer

Abstract PD1 inhibition is effective in patients with metastatic urothelial cancer (mUC), yet a large fraction of patients does not...
Read More

New publication: Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

Abstract In the pre-PSA-detection era, a large proportion of men were diagnosed with metastatic prostate cancer and died of the...
Read More

New publication: Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer

Abstract Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy is recommended for patients with muscle-invasive bladder cancer (MIBC). It has...
Read More

New publication: RNA-based urinary assays for non-muscle invasive bladder cancer

Abstract Purpose of review: To provide an overview of the recent literature on RNA-based molecular urine assays for the diagnosis and...
Read More

Europese erkenning voor Anser prostaatnetwerk

'Beloning voor alle zorgverleners die zich bezig houden met de zorg voor prostaatkankerpatiënten' Het Erasmus MC Kanker Instituut heeft van...
Read More

New publication: Detailed Evaluation of Androgen Deprivation Overtreatment in Prostate Cancer Patients Compared to the European Association of Urology Guidelines Using Long-term Data from the European Randomised Study of Screening for Prostate Cancer Rotterdam

Abstract Background Guidelines on androgen deprivation therapy (ADT) for prostate cancer (PCa) arise from a critical appraisal of scientific evidence,...
Read More

Prestigieuze Amerikaanse subsidie voor blaaskankeronderzoek van dr. T.C.M. Zuiverloon

Amerikaanse onderzoekers hebben samen met uroloog dr. Tahlita Zuiverloon van het Kanker Instituut de prestigieuze R01-grant binnengehaald. Het team krijgt...
Read More

Job listing: Postdoctoral Researcher IMPASSE study

Job description The candidate will be part of the Erasmus MC Urothelial Cancer Research Group (EUCRG) and will be working...
Read More

New publication: Cross-cultural differences in men on active surveillance’ anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study

Abstract Background: Men diagnosed with localized prostate cancer (PCa) on active surveillance (AS) have shown to cope with anxiety caused by...
Read More

BLAASPRAAT interview over blaaskanker met dhr J.L. Boormans MD PhD, uroloog Erasmus Medisch Centrum

Dhr J.L. Boormans MD PhD, uroloog in Erasmus Medisch Centrum, geeft uitleg over o.a. symptomen van blaaskanker en de zorg...
Read More

Nieuw onderzoek ondersteunt invoering screening op prostaatkanker

Moderne screeningsmethode verkleint kans op overdiagnose Mannen die meedoen aan een screening op prostaatkanker en de ziekte blijken te hebben,...
Read More

New publication: Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative

Abstract Background: Active surveillance (AS) is a management option for men diagnosed with low-risk prostate cancer. Opinions differ on whether...
Read More

New publication: Cell Line Characteristics Predict Subsequent Resistance to Androgen Receptor-Targeted Agents (ARTA) in Preclinical Models of Prostate Cancer

Abstract Treatment of prostate cancer (PCa) has changed considerably in the last decade due to the introduction of novel androgen...
Read More

New publication: Kilohertz alternating current neuromodulation of the pudendal nerves: effects on the anal canal and anal sphincter in rats

Abstract The first two objectives were to establish which stimulation parameters of kilohertz frequency alternating current (KHFAC) neuromodulation influence the...
Read More

Radio Rijnmond op bezoek in het lab voor blaaskanker onderzoek

Op 21 juni werden Tahlita Zuiverloon, uroloog en Christiaan de Jong, PhD-candidate afdeling urologie, geïnterviewd door Radio Rijnmond. Het verhaal...
Read More

 

The full archive can be found by clicking here